Israel Englander Talis Biomedical Corp Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.44 - $0.54 $31,768 - $38,988	-72,200 Reduced 44.12%	91,463 $43,000
Q1 2023 May 15, 2023	BUY	$0.48 - $0.64 $25,260 - $33,681	52,627 Added 47.4%	163,663 $80,000
Q4 2022 Feb 14, 2023	SELL	$0.45 - $11.67 $8,251 - $213,981	-18,336 Reduced 14.17%	111,036 $49,000
Q3 2022 Nov 14, 2022	SELL	$0.7 - $10.79 $50,778 - $782,717	-72,541 Reduced 35.93%	129,372 $88,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.1M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.